nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—CYP2C9—brain cancer	0.557	1	CbGaD
Pranlukast—ABCC2—Carboplatin—brain cancer	0.0581	0.287	CbGbCtD
Pranlukast—ABCC2—Etoposide—brain cancer	0.0488	0.241	CbGbCtD
Pranlukast—CYP3A4—Temozolomide—brain cancer	0.0464	0.229	CbGbCtD
Pranlukast—CYP3A4—Lomustine—brain cancer	0.0394	0.195	CbGbCtD
Pranlukast—RNASE3—nose—brain cancer	0.0371	0.336	CbGeAlD
Pranlukast—IL5—nose—brain cancer	0.0337	0.305	CbGeAlD
Pranlukast—CYP3A4—Etoposide—brain cancer	0.00953	0.0471	CbGbCtD
Pranlukast—MUC2—hindbrain—brain cancer	0.00557	0.0503	CbGeAlD
Pranlukast—MUC2—brainstem—brain cancer	0.00319	0.0288	CbGeAlD
Pranlukast—MUC2—telencephalon—brain cancer	0.00283	0.0256	CbGeAlD
Pranlukast—MUC2—gonad—brain cancer	0.00236	0.0214	CbGeAlD
Pranlukast—IL5—endocrine gland—brain cancer	0.00232	0.021	CbGeAlD
Pranlukast—Ospemifene—CYP2C9—brain cancer	0.00213	0.529	CrCbGaD
Pranlukast—MUC2—spinal cord—brain cancer	0.00198	0.0179	CbGeAlD
Pranlukast—Candesartan—CYP2C9—brain cancer	0.0019	0.471	CrCbGaD
Pranlukast—MUC2—endocrine gland—brain cancer	0.00179	0.0161	CbGeAlD
Pranlukast—MUC2—head—brain cancer	0.00176	0.0159	CbGeAlD
Pranlukast—NFKB1—telencephalon—brain cancer	0.00161	0.0146	CbGeAlD
Pranlukast—MUC2—central nervous system—brain cancer	0.00161	0.0145	CbGeAlD
Pranlukast—MUC2—cerebellum—brain cancer	0.00157	0.0142	CbGeAlD
Pranlukast—NFKB1—gonad—brain cancer	0.00135	0.0122	CbGeAlD
Pranlukast—NFKB1—pituitary gland—brain cancer	0.00131	0.0119	CbGeAlD
Pranlukast—MUC2—brain—brain cancer	0.00128	0.0115	CbGeAlD
Pranlukast—NFKB1—endocrine gland—brain cancer	0.00102	0.0092	CbGeAlD
Pranlukast—NFKB1—head—brain cancer	0.00101	0.00909	CbGeAlD
Pranlukast—CYSLTR1—endocrine gland—brain cancer	0.001	0.00904	CbGeAlD
Pranlukast—CYSLTR1—head—brain cancer	0.000987	0.00893	CbGeAlD
Pranlukast—NFKB1—central nervous system—brain cancer	0.000917	0.00829	CbGeAlD
Pranlukast—CYSLTR1—central nervous system—brain cancer	0.000901	0.00815	CbGeAlD
Pranlukast—NFKB1—cerebellum—brain cancer	0.000897	0.00811	CbGeAlD
Pranlukast—NFKB1—brain—brain cancer	0.000728	0.00659	CbGeAlD
Pranlukast—CYSLTR1—brain—brain cancer	0.000715	0.00647	CbGeAlD
Pranlukast—ABCC2—endocrine gland—brain cancer	0.0004	0.00361	CbGeAlD
Pranlukast—CYP2C9—endocrine gland—brain cancer	0.000266	0.00241	CbGeAlD
Pranlukast—CYP3A4—endocrine gland—brain cancer	0.000203	0.00184	CbGeAlD
Pranlukast—CYP3A4—central nervous system—brain cancer	0.000183	0.00165	CbGeAlD
Pranlukast—NFKB1—Signaling by NGF—PDGFRA—brain cancer	9.04e-05	0.000717	CbGpPWpGaD
Pranlukast—IL5—Immune System—VAV1—brain cancer	9.02e-05	0.000716	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—VEGFA—brain cancer	8.94e-05	0.000709	CbGpPWpGaD
Pranlukast—NFKB1—Neural Crest Differentiation—MYC—brain cancer	8.87e-05	0.000704	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ABR—brain cancer	8.83e-05	0.000701	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—APC—brain cancer	8.72e-05	0.000692	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—brain cancer	8.6e-05	0.000683	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GLI2—brain cancer	8.53e-05	0.000677	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—brain cancer	8.44e-05	0.00067	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—brain cancer	8.43e-05	0.000669	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—RELA—brain cancer	8.42e-05	0.000668	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DTX2—brain cancer	8.4e-05	0.000667	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	8.37e-05	0.000664	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—brain cancer	8.37e-05	0.000664	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—MYC—brain cancer	8.34e-05	0.000662	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—CTNNB1—brain cancer	8.24e-05	0.000654	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP2C9—brain cancer	8.17e-05	0.000648	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SHH—brain cancer	8.07e-05	0.000641	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IRS2—brain cancer	8.07e-05	0.000641	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	8.06e-05	0.00064	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—RELA—brain cancer	8.04e-05	0.000638	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CDKN2A—brain cancer	8.03e-05	0.000637	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GLI1—brain cancer	8.02e-05	0.000636	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—CCND1—brain cancer	8.01e-05	0.000636	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—ERBB2—brain cancer	7.99e-05	0.000634	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDK4—brain cancer	7.94e-05	0.00063	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	7.94e-05	0.00063	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IRS2—brain cancer	7.93e-05	0.00063	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—SKP2—brain cancer	7.93e-05	0.00063	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—brain cancer	7.92e-05	0.000628	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.83e-05	0.000622	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—MYC—brain cancer	7.83e-05	0.000621	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—VAV1—brain cancer	7.8e-05	0.000619	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—brain cancer	7.8e-05	0.000619	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TRPC6—brain cancer	7.79e-05	0.000618	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	7.73e-05	0.000614	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—RELA—brain cancer	7.73e-05	0.000613	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IL2—brain cancer	7.69e-05	0.00061	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SMO—brain cancer	7.65e-05	0.000608	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PTCH1—brain cancer	7.65e-05	0.000608	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL2—brain cancer	7.63e-05	0.000606	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SUFU—brain cancer	7.6e-05	0.000603	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.52e-05	0.000597	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—RELA—brain cancer	7.44e-05	0.00059	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CCND1—brain cancer	7.44e-05	0.00059	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—RELA—brain cancer	7.43e-05	0.00059	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—ERBB2—brain cancer	7.39e-05	0.000587	CbGpPWpGaD
Pranlukast—IL5—Immune System—PDGFRA—brain cancer	7.39e-05	0.000586	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—APC—brain cancer	7.37e-05	0.000585	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GFAP—brain cancer	7.33e-05	0.000582	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TRPC6—brain cancer	7.25e-05	0.000575	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—STAT3—brain cancer	7.19e-05	0.00057	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—VAV1—brain cancer	7.09e-05	0.000563	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	6.99e-05	0.000554	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HEY1—brain cancer	6.95e-05	0.000552	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—PIK3CG—brain cancer	6.9e-05	0.000548	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—brain cancer	6.85e-05	0.000544	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—CTNNB1—brain cancer	6.82e-05	0.000541	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DLL1—brain cancer	6.82e-05	0.000541	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—VEGFA—brain cancer	6.81e-05	0.00054	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—brain cancer	6.75e-05	0.000536	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.64e-05	0.000527	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.58e-05	0.000522	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VEGFA—brain cancer	6.53e-05	0.000519	CbGpPWpGaD
Pranlukast—IL5—Immune System—IRS2—brain cancer	6.49e-05	0.000515	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—brain cancer	6.43e-05	0.00051	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—MYC—brain cancer	6.43e-05	0.00051	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTCH2—brain cancer	6.37e-05	0.000506	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—VAV1—brain cancer	6.29e-05	0.0005	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—EGFR—brain cancer	6.29e-05	0.000499	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PIK3CG—brain cancer	6.27e-05	0.000498	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HES5—brain cancer	6.17e-05	0.00049	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—HES1—brain cancer	6.13e-05	0.000487	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOTCH2—brain cancer	6.12e-05	0.000486	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN2A—brain cancer	6.07e-05	0.000482	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—VAV1—brain cancer	6.04e-05	0.00048	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—STRADA—brain cancer	5.99e-05	0.000475	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MYC—brain cancer	5.97e-05	0.000473	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—STAT3—brain cancer	5.94e-05	0.000472	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CTNNB1—brain cancer	5.92e-05	0.00047	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—MYC—brain cancer	5.9e-05	0.000468	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.89e-05	0.000468	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—STAT3—brain cancer	5.85e-05	0.000465	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—RELA—brain cancer	5.84e-05	0.000463	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—EGFR—brain cancer	5.83e-05	0.000463	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VAV1—brain cancer	5.83e-05	0.000463	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—brain cancer	5.8e-05	0.00046	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SHH—brain cancer	5.79e-05	0.00046	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.79e-05	0.000459	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—EGFR—brain cancer	5.77e-05	0.000458	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	5.74e-05	0.000456	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.73e-05	0.000454	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TRPC6—brain cancer	5.59e-05	0.000444	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—RELA—brain cancer	5.57e-05	0.000442	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	5.54e-05	0.000439	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SMO—brain cancer	5.49e-05	0.000436	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTCH1—brain cancer	5.49e-05	0.000436	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—RELA—brain cancer	5.48e-05	0.000435	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—ERBB2—brain cancer	5.44e-05	0.000432	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.33e-05	0.000423	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—brain cancer	5.28e-05	0.000419	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.21e-05	0.000413	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.19e-05	0.000412	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PDGFRA—brain cancer	5.15e-05	0.000409	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—brain cancer	5.12e-05	0.000407	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.06e-05	0.000402	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HES1—brain cancer	5.02e-05	0.000398	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL2—brain cancer	5.02e-05	0.000398	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.01e-05	0.000398	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ABR—brain cancer	5e-05	0.000397	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—PIK3CG—brain cancer	4.96e-05	0.000393	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PDGFRA—brain cancer	4.95e-05	0.000393	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—brain cancer	4.94e-05	0.000392	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—brain cancer	4.9e-05	0.000389	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—IL2—brain cancer	4.86e-05	0.000386	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—brain cancer	4.85e-05	0.000385	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GLI2—brain cancer	4.83e-05	0.000383	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SKP2—brain cancer	4.81e-05	0.000382	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CDK4—brain cancer	4.81e-05	0.000382	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PDGFRA—brain cancer	4.78e-05	0.000379	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—HES1—brain cancer	4.67e-05	0.000371	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SPP1—brain cancer	4.64e-05	0.000368	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GLI1—brain cancer	4.54e-05	0.00036	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IRS2—brain cancer	4.53e-05	0.000359	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PIK3CG—brain cancer	4.5e-05	0.000357	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MYC—brain cancer	4.5e-05	0.000357	CbGpPWpGaD
Pranlukast—IL5—Immune System—RELA—brain cancer	4.48e-05	0.000355	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—brain cancer	4.47e-05	0.000355	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—brain cancer	4.47e-05	0.000355	CbGpPWpGaD
Pranlukast—IL5—Immune System—ERBB2—brain cancer	4.45e-05	0.000353	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—STAT3—brain cancer	4.42e-05	0.000351	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL2—brain cancer	4.41e-05	0.00035	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.41e-05	0.00035	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—brain cancer	4.4e-05	0.000349	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOTCH2—brain cancer	4.39e-05	0.000349	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.37e-05	0.000347	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—IRS2—brain cancer	4.35e-05	0.000345	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SUFU—brain cancer	4.3e-05	0.000341	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—STAT3—brain cancer	4.22e-05	0.000335	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IRS2—brain cancer	4.19e-05	0.000333	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VAV1—brain cancer	4.19e-05	0.000332	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GFAP—brain cancer	4.15e-05	0.000329	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—STAT3—brain cancer	4.15e-05	0.000329	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.06e-05	0.000322	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—brain cancer	4.03e-05	0.00032	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.97e-05	0.000315	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—brain cancer	3.94e-05	0.000313	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HEY1—brain cancer	3.93e-05	0.000312	CbGpPWpGaD
Pranlukast—IL5—Immune System—CTNNB1—brain cancer	3.89e-05	0.000309	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DLL1—brain cancer	3.86e-05	0.000306	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—brain cancer	3.77e-05	0.000299	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APC—brain cancer	3.7e-05	0.000294	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PIK3CG—brain cancer	3.7e-05	0.000294	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—brain cancer	3.69e-05	0.000293	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—VAV1—brain cancer	3.67e-05	0.000291	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CDK4—brain cancer	3.66e-05	0.000291	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HES1—brain cancer	3.6e-05	0.000286	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RELA—brain cancer	3.54e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ERBB2—brain cancer	3.51e-05	0.000279	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—brain cancer	3.49e-05	0.000277	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.48e-05	0.000276	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PDGFRA—brain cancer	3.43e-05	0.000272	CbGpPWpGaD
Pranlukast—IL5—Immune System—STAT3—brain cancer	3.39e-05	0.000269	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—brain cancer	3.38e-05	0.000268	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—brain cancer	3.37e-05	0.000268	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.33e-05	0.000265	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SPP1—brain cancer	3.33e-05	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SHH—brain cancer	3.28e-05	0.00026	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—brain cancer	3.17e-05	0.000251	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TRPC6—brain cancer	3.16e-05	0.000251	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—RELA—brain cancer	3.12e-05	0.000248	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTCH1—brain cancer	3.11e-05	0.000247	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SMO—brain cancer	3.11e-05	0.000247	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ERBB2—brain cancer	3.1e-05	0.000246	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—brain cancer	3.08e-05	0.000245	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CTNNB1—brain cancer	3.07e-05	0.000244	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IRS2—brain cancer	3.01e-05	0.000239	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PDGFRA—brain cancer	3e-05	0.000238	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RELA—brain cancer	3e-05	0.000238	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ERBB2—brain cancer	2.98e-05	0.000237	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RELA—brain cancer	2.89e-05	0.00023	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ERBB2—brain cancer	2.88e-05	0.000228	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CTNNB1—brain cancer	2.72e-05	0.000216	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—brain cancer	2.71e-05	0.000215	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RELA—brain cancer	2.69e-05	0.000214	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—STAT3—brain cancer	2.68e-05	0.000213	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ERBB2—brain cancer	2.68e-05	0.000213	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APC—brain cancer	2.66e-05	0.000211	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PIK3CG—brain cancer	2.66e-05	0.000211	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRS2—brain cancer	2.64e-05	0.000209	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—brain cancer	2.61e-05	0.000207	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCND1—brain cancer	2.54e-05	0.000202	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CTNNB1—brain cancer	2.52e-05	0.0002	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOTCH2—brain cancer	2.49e-05	0.000197	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—brain cancer	2.44e-05	0.000193	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—brain cancer	2.42e-05	0.000192	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VAV1—brain cancer	2.37e-05	0.000188	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CTNNB1—brain cancer	2.34e-05	0.000186	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—brain cancer	2.22e-05	0.000176	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—STAT3—brain cancer	2.19e-05	0.000174	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—brain cancer	2.15e-05	0.000171	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RELA—brain cancer	2.08e-05	0.000165	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—brain cancer	2.07e-05	0.000164	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ERBB2—brain cancer	2.06e-05	0.000164	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—brain cancer	2.06e-05	0.000164	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—STAT3—brain cancer	2.04e-05	0.000162	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HES1—brain cancer	2.04e-05	0.000162	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MYC—brain cancer	2.04e-05	0.000162	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—brain cancer	1.99e-05	0.000158	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDGFRA—brain cancer	1.94e-05	0.000154	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SPP1—brain cancer	1.88e-05	0.00015	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—brain cancer	1.87e-05	0.000148	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—brain cancer	1.86e-05	0.000147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—brain cancer	1.82e-05	0.000145	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RELA—brain cancer	1.82e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERBB2—brain cancer	1.81e-05	0.000143	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CTNNB1—brain cancer	1.81e-05	0.000143	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—BSG—brain cancer	1.8e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IRS2—brain cancer	1.7e-05	0.000135	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—brain cancer	1.67e-05	0.000133	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—brain cancer	1.64e-05	0.00013	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—brain cancer	1.59e-05	0.000126	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTNNB1—brain cancer	1.58e-05	0.000126	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—STAT3—brain cancer	1.57e-05	0.000125	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—IDH1—brain cancer	1.55e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PIK3CG—brain cancer	1.51e-05	0.000119	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APC—brain cancer	1.51e-05	0.000119	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MYC—brain cancer	1.46e-05	0.000116	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—brain cancer	1.43e-05	0.000114	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP2C9—brain cancer	1.4e-05	0.000111	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—STAT3—brain cancer	1.38e-05	0.000109	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.26e-05	0.0001	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—brain cancer	1.25e-05	9.94e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ENO2—brain cancer	1.22e-05	9.72e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—brain cancer	1.2e-05	9.53e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—BSG—brain cancer	1.19e-05	9.43e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RELA—brain cancer	1.18e-05	9.33e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ERBB2—brain cancer	1.17e-05	9.28e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—brain cancer	1.06e-05	8.41e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—brain cancer	1.03e-05	8.2e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CTNNB1—brain cancer	1.02e-05	8.12e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—IDH1—brain cancer	1.02e-05	8.11e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—brain cancer	9e-06	7.14e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—STAT3—brain cancer	8.91e-06	7.07e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MYC—brain cancer	8.28e-06	6.57e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—brain cancer	8.1e-06	6.43e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ENO2—brain cancer	8.08e-06	6.41e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—brain cancer	6.8e-06	5.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3CG—brain cancer	5.62e-06	4.46e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3CG—brain cancer	3.7e-06	2.94e-05	CbGpPWpGaD
